Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
16 June 2018 - 3:09AM
Edgar (US Regulatory)
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
SEC
FILE
NUMBER
000-55008
|
(Check
one):
[ ]
Form 10-K [ ] Form 20-F [ ] Form 11-K
[X]
Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
For
Period Ended:
April 30, 2018
|
[ ] Transition Report on Form 10-K
|
|
|
[ ] Transition Report on Form 20-F
|
|
|
[ ] Transition Report on Form 11-K
|
|
|
[ ] Transition Report on Form 10-Q
|
|
|
[ ] Transition Report on Form N-SAR
|
|
For
the Transition Period Ended: _________________
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I - REGISTRANT INFORMATION
BIOTECH
PRODUCTS SERVICES AND RESEARCH, INC.
Full
Name of Registrant
N/A
Former
Name if Applicable
4045
Sheridan Ave., Suite 239
Address
of Principal Executive Office
(Street and Number)
Miami,
FL 33140
City,
State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate)
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
|
[x]
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject Annual report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III - NARRATIVE
State below in reasonable detail why Forms
10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed
time period.
The Registrant is unable to file its Quarterly
Report on Form 10-Q for the fiscal quarter ended April 30, 2018 (the “
Report
”) within the prescribed period
due to ministerial difficulties. Because the audit of the financial statements for the year ended October 31, 2017 has not been
completed, the review of the Report cannot be completed without unreasonable effort or expense.
PART IV - OTHER
INFORMATION
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
IAN BOTHWELL
|
|
(888)
|
|
963-7881
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2)
|
Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer
is no, identify report(s).
[ ] Yes [ X ] No
|
|
|
(3)
|
Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
[ ] Yes [X] No
|
If so, attach an explanation
of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
BIOTECH PRODUCTS SERVICES AND RESEARCH,
INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed
on its behalf by the undersigned hereunto duly authorized.
Dated: June 15, 2018
|
By:
|
/s/ Ian Bothwell
|
|
|
Ian Bothwell
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|